Cesarean section in a patient with familial cardiomyopathy and a cardioverter-defibrillator

Canadian Journal of Anesthesia

Volumn 53, Issue 5, 2006, Pages 478-481

  Frost, Don A ^a   Dolak, James A ^b  

^a Department of Anesthesiology   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CATECHOLAMINE; FENTANYL; MISOPROSTOL; OXYTOCIN; ROPIVACAINE;

ADULT; ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; CARDIOMYOPATHY; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; CESAREAN SECTION; DEFIBRILLATOR; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; ELECTROCARDIOGRAPHY MONITORING; EPIDURAL ANESTHESIA; EXPERIENCE; FAMILIAL DISEASE; FEMALE; FETUS OUTCOME; GENERAL ANESTHESIA; GESTATIONAL AGE; HEART PACING; HEART RHYTHM; HEMODYNAMICS; HUMAN; LABOR INDUCTION; LUMBAR SPINE; OBSTETRIC ANALGESIA; OBSTETRIC PATIENT; PERINATAL PERIOD; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REGIONAL ANESTHESIA; TREATMENT FAILURE;

ADULT; ANALGESIA, EPIDURAL; ANALGESIA, OBSTETRICAL; ANALGESIA, PATIENT-CONTROLLED; ANESTHESIA, EPIDURAL; ANESTHESIA, OBSTETRICAL; ANESTHETICS, LOCAL; ARRHYTHMIA; BUPIVACAINE; CARDIOMYOPATHIES; CESAREAN SECTION; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LABOR, INDUCED; PAIN, POSTOPERATIVE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME;

EID: 33745771146     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03022620     Document Type: Article

References (17)

1. Johnston AJ, Hall JM, Levy DM. Anesthesia with remifentanil and rocuronium for caesarean section in a patient with long-QT syndrome and an automatic implantable cardioverter-defibrillator. Int J Obstet Anesth 2000; 9: 133-6.
2. Olufolabi AJ, Charlton GA, Allen SA, Mettam IM, Roberts PR. Use of implantable cardioverter defibrillator and anti-arrhythmic agents in a parturient. Br J Anaesth 2002; 89: 652-5.
3. Isaacs JD, Mulholland DH, Hess LW, Allbert JR, Martin RW. Pregnancy in a woman with an automatic implantable cardioverter-defibrillator. A case report. J Reprod Med 1993; 36: 487-8.
4. Shnider SM, Abboud TK, Artal R, Henriksen EH, Stefani SJ, Levinson G. Maternal catecholamines decrease during labor after lumbar epidural anesthesia. Am J Obstet Gynecol 1983; 147: 13-5.
5. Dubin AM, Batsford WP, Lewis RJ, Rosenfeld LE. Quality-of-tifc in patients receiving implantable cardioverter defibrillators at or before age 40. Pacing Clin Electrophysiol 1996; 19(11 Pt 1): 1555-9.
6. Gallagher RD, McKinley S, Mangan B, Pelletier D, Squire J, Mitten-Lewis S. The impact of the implantable cardioverter defibrillator on quality of life. Am J Crit Care 1997; 6: 16-24.
7. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy. A safe combination? Circulation 1997; 96: 2808-12.
8. Lee SH, Chen SA, Wu TJ, et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol 1995; 76: 675-8.
9. Banwell BR, Morley-Forster P, Krause R. Decreased incidence of complications in parturients with the Arrow (Flex-Tip Plus™) epidural catheter. Can J Anaesth 1998; 45: 370-2.
10. Greene NM, Brull SJ. Physiology of Spinal Anesthesia, 4th ed. Baltimore: Williams & Wilkins; 1993.
11. Denson DD, Knapp RM, Turner P, Thompson GA. Serum bupivacaine concentrations in term parturients following continuous epidural analgesia for labor and delivery. Ther Drug Monit 1984; 6: 393-8.
12. Flynn RJ, McMurray TJ, Dwyer R, Moore J. Comparison of plasma bupivacaine concentrations during continuous extradural infusion for labour. Br J Anaesth 1988; 61: 382-4.
13. Eyres RL, Bishop W, Oppenheim RC, Brown TC. Plasma bupivacaine concentrations in children during caudal epidural analgesia. Anaesth Intensive Care 1983; 11: 20-2.
14. Downing JW, Johnson VH, Gonzalez HF, Arney TL, Herman NL, Johnson RF. The pharmacokinetics of epidural lidocaine and bupivacaine during cesarean section. Anesth Analg 1997; 84: 527-32.
15. Reynolds F. A comparison of the potential toxicity of bupivacaine, lignocaine, and mepivacaine during epidural blockade for surgery. Br J Anaesth 1971; 43: 567-72.
16. Picard S, Rouet R, Flais F, et al. Proarrhythmic and antiarrhythmic effects of bupivacaine in an in vitro model of myocardial ischemia and reperfusion. Anesthesiology 1998; 88: 1318-29.
17. Kulier AH, Woehlck HJ, Hogan QH, et al. Epinephrine dysrhythmogenicity is not enhanced by subtoxic bupivacaine in dogs. Anesth Analg 1996; 83: 62-7.